Answers are grounded in this paper and cite their sources.
Solvolysis of 1,3-di-tert-butyl-5-methyl-5-cyclopenta-1,3-dienyl trifluoroacetate (15a) occurs with a strong dependence on solvent ionizing power (m = 0.97), and gives products of substitution, allylic and skeletal rearrangement with substitution, and elimination. These results are characteristic of a process involving an intermediate carbocation, and provide the first measurements of the kinetics of formation of a cyclopentadienyl cation, the prototypical 4π-electron carbocation destabilized by antiaromaticity. The reactivity of 15a in 2,2,2-trifluoroethanol at 25 °C is calculated to be lower than those of analogous fluorenyl and indenyl derivatives by factors of 3 × 104 and 4 × 102, and is exceeded by that calculated for 1,3-dimethyl-3-cyclopentenyl trifluoroacetate by a factor of 1014, showing the large carbocation destabilizing effects of antiaromaticity.
No takes yet. Share an insight, caveat, or question.
Allen et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: